Vir Biotechnology, Inc. (NASDAQ:VIR) Insider Sells $64,175.00 in Stock

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) insider Steven J. Rice sold 2,500 shares of Vir Biotechnology stock in a transaction on Thursday, June 1st. The stock was sold at an average price of $25.67, for a total value of $64,175.00. Following the sale, the insider now directly owns 106,840 shares of the company’s stock, […]

Related Keywords

Canada ,China ,Alaska ,United States , ,Commonwealth Equity Services ,Morgan Stanley ,Nasdaq ,Vir Biotechnology Inc ,Securities Exchange Commission ,Alaska Department Of Revenue ,China Universal Asset Management Co ,Summerhaven Investment Management ,Needham Company ,Royal Bank ,Vir Biotechnology ,Get Rating ,Exchange Commission ,Haven Investment Management ,Universal Asset Management ,Alaska Department ,Equity Services ,Vir Biotechnology Daily ,Nasdaq Vir ,Ivir ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,